Literature DB >> 25308960

7 Tesla magnetic resonance imaging: a closer look at substantia nigra anatomy in Parkinson's disease.

Stéphane Lehéricy1, Eric Bardinet, Cyril Poupon, Marie Vidailhet, Chantal François.   

Abstract

A hallmark of Parkinson's disease (PD) is the progressive neurodegeneration of dopaminergic neurons in the substantia nigra pars compacta (SNc). Dopaminergic denervation is commonly imaged using radiotracer imaging in target structures such as the striatum. Until recently, imaging made only a modest contribution to detecting neurodegenerative changes in the substantia nigra (SN) directly. Histologically, the SN is subdivided into the ventral pars reticulata and the dorsal pars compacta, which is composed of dopaminergic neurons. In humans, dopaminergic neurons, which are known to accumulate neuromelanin, form clusters of cells (nigrosomes) that penetrate deep into the SN pars reticulata (SNr). The SNr contains higher levels of iron than the SNc in normal subjects. Neuromelanin and T2*-weighted imaging therefore better detect the SNc and the SNr, respectively. The development of ultra-high field 7 Tesla (7T) magnetic resonance imaging (MRI) provided the increase in spatial resolution and in contrast that was needed to detect changes in SN morphology. 7T MRI allows visualization of nigrosome-1 as a hyperintense signal area on T2*-weighted images in the SNc of healthy subjects and its absence in PD patients, probably because of the loss of melanized neurons and the increase of iron deposition. This review is designed to provide a better understanding of the correspondence between the outlines and subdivisions of the SN detected using different MRI contrasts and the histological organization of the SN. The recent findings obtained at 7T will then be presented in relation to histological knowledge.
© 2014 International Parkinson and Movement Disorder Society.

Entities:  

Keywords:  iron; neuromelanin; nigrosome; substantia nigra pars compacta; substantia nigra pars reticulata

Mesh:

Year:  2014        PMID: 25308960     DOI: 10.1002/mds.26043

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  40 in total

1.  Clinical utility of visualisation of nigrosome-1 in patients with Parkinson's disease.

Authors:  Albert Stezin; Rajini M Naduthota; Ragasudha Botta; Shriram Varadharajan; Abhishek Lenka; Jitender Saini; Ravi Yadav; Pramod Kumar Pal
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

2.  Toward an In Vivo Neuroimaging Template of Human Brainstem Nuclei of the Ascending Arousal, Autonomic, and Motor Systems.

Authors:  Marta Bianciardi; Nicola Toschi; Brian L Edlow; Cornelius Eichner; Kawin Setsompop; Jonathan R Polimeni; Emery N Brown; Hannah C Kinney; Bruce R Rosen; Lawrence L Wald
Journal:  Brain Connect       Date:  2015-08-11

3.  Mapping tracts in the human subthalamic area by 11.7T ex vivo diffusion tensor imaging.

Authors:  Kenichi Oishi; Susumu Mori; Juan C Troncoso; Frederick A Lenz
Journal:  Brain Struct Funct       Date:  2020-04-17       Impact factor: 3.270

Review 4.  Structural Imaging in Parkinson's Disease: New Developments.

Authors:  Stéphane Prange; Elise Metereau; Stéphane Thobois
Journal:  Curr Neurol Neurosci Rep       Date:  2019-06-18       Impact factor: 5.081

Review 5.  Challenges and opportunities for brainstem neuroimaging with ultrahigh field MRI.

Authors:  Roberta Sclocco; Florian Beissner; Marta Bianciardi; Jonathan R Polimeni; Vitaly Napadow
Journal:  Neuroimage       Date:  2017-02-21       Impact factor: 6.556

6.  In vivo functional connectome of human brainstem nuclei of the ascending arousal, autonomic, and motor systems by high spatial resolution 7-Tesla fMRI.

Authors:  Marta Bianciardi; Nicola Toschi; Cornelius Eichner; Jonathan R Polimeni; Kawin Setsompop; Emery N Brown; Matti S Hämäläinen; Bruce R Rosen; Lawrence L Wald
Journal:  MAGMA       Date:  2016-04-28       Impact factor: 2.310

Review 7.  Role of iron in neurodegenerative diseases.

Authors:  Kai Li; Heinz Reichmann
Journal:  J Neural Transm (Vienna)       Date:  2016-01-21       Impact factor: 3.575

8.  Mutant Huntingtin Causes a Selective Decrease in the Expression of Synaptic Vesicle Protein 2C.

Authors:  Chaohua Peng; Gaochun Zhu; Xiangqian Liu; He Li
Journal:  Neurosci Bull       Date:  2018-04-30       Impact factor: 5.203

Review 9.  MRI biomarkers of motor and non-motor symptoms in Parkinson's disease.

Authors:  Sephira G Ryman; Kathleen L Poston
Journal:  Parkinsonism Relat Disord       Date:  2019-10-10       Impact factor: 4.891

Review 10.  Nigrosome Imaging and Neuromelanin Sensitive MRI in Diagnostic Evaluation of Parkinsonism.

Authors:  Nicola Pavese; Yen F Tai
Journal:  Mov Disord Clin Pract       Date:  2018-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.